drugset / Trial / NCT00005056
Bryostatin 1 In Treating Patients With Progressive Kidney Cancer
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of bryostatin 1 in treating patients who have progressive kidney cancer
Timeline
- Start
- 1999-03
- Primary completion
- —
- Completion
- 2006-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | bryostatin 1 | Small molecule | — | Intravenous |